Topical application of imiquimod, a ligand of TLR7 and TLR8, induces a psoriasis-like skin inflammation with typical microscopic and macroscopic psoriatic markers in mice, and is the most commonly used psoriasis animal model [38]. Here, TLR8 is linked to psoriasis.